Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Go back to Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Gossamer Bio Inc. (GOSS) Misses Q2 EPS by 4c

August 9, 2021 4:52 PM EDT

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.80), $0.04 worse than the analyst estimate of ($0.76).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

... More